Xiaolin Cui

449 total citations · 1 hit paper
9 papers, 281 citations indexed

About

Xiaolin Cui is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Xiaolin Cui has authored 9 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Neurology. Recurrent topics in Xiaolin Cui's work include Alzheimer's disease research and treatments (4 papers), MicroRNA in disease regulation (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Xiaolin Cui is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), MicroRNA in disease regulation (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Xiaolin Cui collaborates with scholars based in China. Xiaolin Cui's co-authors include Cuicui Wang, Yingchao Liu, Xueying Wang, Zhiming Lü, Shuai Zong, Le Wang, Shuang Wu, Pengcheng Xia, Zhiming Lu and Le Wang and has published in prestigious journals such as Frontiers in Immunology, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Xiaolin Cui

9 papers receiving 278 citations

Hit Papers

The effects of microglia-associated neuroinflammation on ... 2023 2026 2024 2025 2023 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Cui China 7 120 101 97 51 36 9 281
Aishat Motolani United States 7 179 1.5× 99 1.0× 92 0.9× 50 1.0× 48 1.3× 11 354
Chenghuan Song China 7 186 1.6× 73 0.7× 134 1.4× 84 1.6× 37 1.0× 12 352
Pabbala Veeresh India 5 191 1.6× 112 1.1× 48 0.5× 65 1.3× 13 0.4× 5 376
Geetesh Verma India 4 183 1.5× 105 1.0× 46 0.5× 64 1.3× 12 0.3× 6 355
Aurel Simion Romania 6 136 1.1× 181 1.8× 40 0.4× 43 0.8× 16 0.4× 6 371
Jiagui Huang China 10 233 1.9× 121 1.2× 53 0.5× 52 1.0× 13 0.4× 17 455
Ai-Li Xu China 7 182 1.5× 45 0.4× 79 0.8× 120 2.4× 18 0.5× 12 369
Dezhen Tu China 9 160 1.3× 148 1.5× 68 0.7× 23 0.5× 45 1.3× 11 384
Ang Xing China 7 118 1.0× 57 0.6× 132 1.4× 25 0.5× 19 0.5× 10 321
Aijuan Yan China 12 140 1.2× 154 1.5× 55 0.6× 33 0.6× 17 0.5× 24 421

Countries citing papers authored by Xiaolin Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Cui more than expected).

Fields of papers citing papers by Xiaolin Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Cui. The network helps show where Xiaolin Cui may publish in the future.

Co-authorship network of co-authors of Xiaolin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Cui. A scholar is included among the top collaborators of Xiaolin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Cui. Xiaolin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Liu, Yingchao, Pengcheng Xia, Shuai Zong, et al.. (2024). Inhibition of Alzheimer's disease by 4-octyl itaconate revealed by RNA-seq transcriptome analysis. European Journal of Pharmacology. 968. 176432–176432. 8 indexed citations
2.
Zhang, Li, Hua Li, Xiaolin Cui, et al.. (2024). 4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2/HO‐1 signalling pathway. Journal of Cellular and Molecular Medicine. 28(7). e18207–e18207. 13 indexed citations
3.
Xia, Pengcheng, Huijun Ma, Jing Chen, et al.. (2023). Differential expression of pyroptosis-related genes in the hippocampus of patients with Alzheimer’s disease. BMC Medical Genomics. 16(1). 56–56. 4 indexed citations
4.
Cui, Xiaolin, Shuai Zong, Cuicui Wang, et al.. (2023). Omaveloxolone ameliorates cognitive dysfunction in APP/PS1 mice by stabilizing the STAT3 pathway. Life Sciences. 335. 122261–122261. 11 indexed citations
5.
Wang, Cuicui, Xiaolin Cui, Yingchao Liu, et al.. (2023). Attenuated memory impairment and neuroinflammation in Alzheimer’s disease by aucubin via the inhibition of ERK-FOS axis. International Immunopharmacology. 126. 111312–111312. 10 indexed citations
6.
Wang, Cuicui, Shuai Zong, Xiaolin Cui, et al.. (2023). The effects of microglia-associated neuroinflammation on Alzheimer’s disease. Frontiers in Immunology. 14. 1117172–1117172. 165 indexed citations breakdown →
7.
Wu, Jianzhang, et al.. (2023). Green synthesis and anti-tumor efficacy via inducing pyroptosis of novel 1H-benzo[e]indole-2(3H)-one spirocyclic derivatives. Bioorganic Chemistry. 142. 106930–106930. 4 indexed citations
8.
Cui, Xiaolin, et al.. (2022). Molecular mechanisms and clinical applications of exosomes in prostate cancer. Biomarker Research. 10(1). 56–56. 22 indexed citations
9.
Xia, Pengcheng, Jing Chen, Yingchao Liu, et al.. (2022). MicroRNA-22-3p ameliorates Alzheimer’s disease by targeting SOX9 through the NF-κB signaling pathway in the hippocampus. Journal of Neuroinflammation. 19(1). 180–180. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026